Synthesis, structure, DNA/protein binding, molecular docking and in vitro anticancer activity of two Schiff base coordinated copper(II) complexes

Thi

2020

Journal of Chemistry

A series of platinum(II) complexes with chiral Schiff base ligands derived from various salicylaldehydes with (R,R′)- and (S,S′)-cyclohexanediamine were synthesized and characterized by ESI-MS, IR, and NMR. Obtained spectra with typical signals were in agreement with suggested molecular formulae of the complexes. Their photophysical properties were studied by UV-visible and emission spectroscopies. The UV-Vis showed the typical band with low energy at visible range 400–500 nm for MLCT, and this band can emit the luminescent band with emission maximum wavelengths at 529–595 nm. The in vitro cytotoxicity of obtained platinum(II) complexes was screened for KB and MCF-7 human cancer cell lines. The results showed that (S)-enantiomers were more active than (R)-enantiomers and the different positions of methoxy group in salicyl ring gave different cytotoxicities.

Section: Resultssupporting

confidence: 55%

Section: Resultsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

“…ese coordination compounds have also exhibited wonderful biological applications including antimicrobial, antifungal, anti-inflammatory, and anticancer activity [11][12][13][14][15].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Synthesis, Characterization, and In Vitro Cytotoxicity of Platinum(II) Complexes Bearing Chiral Tetradentate Salicylaldimine Ligands

Thi

2020

Journal of Chemistry

“…Furthermore, there have been numerous reports on the investigation of interactions between serum proteins with metal complexes such as Cu II [ 17 , 18 ], Ru III , Ru II [ 19 , 20 ], Pt IV , or Pt II [ 21 , 22 ]. In general, linking proteins with metal complexes can change their biological activity.…”

Section: Introductionmentioning

confidence: 99%

Interaction between DNA, Albumin and Apo-Transferrin and Iridium(III) Complexes with Phosphines Derived from Fluoroquinolones as a Potent Anticancer Drug

et al. 2021

A group of cytotoxic half-sandwich iridium(III) complexes with aminomethyl(diphenyl)phosphine derived from fluoroquinolone antibiotics exhibit the ability to (i) accumulate in the nucleus, (ii) induce apoptosis, (iii) activate caspase-3/7 activity, (iv) induce the changes in cell cycle leading to G2/M phase arrest, and (v) radicals generation. Herein, to elucidate the cytotoxic effects, we investigated the interaction of these complexes with DNA and serum proteins by gel electrophoresis, fluorescence spectroscopy, circular dichroism, and molecular docking studies. DNA binding experiments established that the complexes interact with DNA by moderate intercalation and predominance of minor groove binding without the capability to cause a double-strand cleavage. The molecular docking study confirmed two binding modes: minor groove binding and threading intercalation with the fluoroquinolone part of the molecule involved in pi stacking interactions and the Ir(III)-containing region positioned within the major or minor groove. Fluorescence spectroscopic data (HSA and apo-Tf titration), together with molecular docking, provided evidence that Ir(III) complexes can bind to the proteins in order to be transferred. All the compounds considered herein were found to bind to the tryptophan residues of HSA within site I (subdomain II A). Furthermore, Ir(III) complexes were found to dock within the apo-Tf binding site, including nearby tyrosine residues.

Tridentate Schiff base and 4,4′‐bipyridine coordinated di/polynuclear Cu (II) complexes: Synthesis, crystal structure, DNA/protein binding and catecholase activity

Bhunia

Bertolasi

Manna

2020

Applied Organom Chemis

Self Cite

4,4′‐bipyridine bridged two Cu (II) complexes, [Cu2L12(4,4′‐bipy)(H2O)2](ClO4)2 (1) and [Cu2L22(4,4′‐bipy)]n·(2H2O)n (2) (where, HL1 = 2‐[(3‐methylamino‐propylimino)‐methyl]‐phenol, H2L2 = 3‐[(2‐hydroxy‐3‐methoxy‐benzylidene)‐amino]‐propionic acid, and 4,4′‐bipy = 4,4′‐bipyridine) have been synthesized and characterized by single crystal structure determination, mass spectrometry, FT‐IR, electronic absorption, and emission spectroscopy. Complex 1 is dinuclear cationic compound and counter balanced by perchlorate anion, whereas complex 2 possesses 1D poly‐nuclear structure. Both the complexes crystallize in monoclinic system with P21/c space group and the copper centers possess square pyramidal geometry. H‐bonding, C‐H···π, π···π interactions results the formation of two dimentional supramolecular structure for both the complexes. Interactions of complexes with bovine serum albumins (BSA) and human serum albumins (HSA) have been studied by using electronic absorption and emission spectroscopic technique. The calculated values of binding constants (Kb) are (9.22 ± 0.26) × 105 L mol−1 (1‐BSA), (7.19 ± 0.16) × 105 L mol−1 (1‐HSA), (5.05 ± 0.20) × 105 L mol−1 (2‐BSA) and (3.56 ± 0.25) × 105 L mol−1 (2‐HSA). The mechanism of serum albumins‐complex interactions have been investigated by fluorescence lifetime measurement. Fluorescence spectroscopic studies indicate that both the complexes interact with calf thymas‐DNA. Catecholase activity of the complexes has been studied in methanol using 3,5‐di‐tert‐butylcatechol (3,5‐DTBC) as substrate and the result show that both the complexes are active for catalytic oxidation of 3,5‐DTBC to 3,5‐di‐tert‐butylquinone (3,5‐DTBQ) in presence of molecular oxygen. Calculated values of turnover numbers are 71.81 ± 1.04 h−1 and 69.45 ± 0.74 h−1 for 1 and 2, respectively.